Silence Therapeutics (SLNCF) Net Margin (2020 - 2025)
Historic Net Margin for Silence Therapeutics (SLNCF) over the last 6 years, with Q3 2025 value amounting to 13181.13%.
- Silence Therapeutics' Net Margin fell 105653600.0% to 13181.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 249.86%, marking a year-over-year increase of 1580600.0%. This contributed to the annual value of 104.74% for FY2024, which is 649700.0% up from last year.
- Silence Therapeutics' Net Margin amounted to 13181.13% in Q3 2025, which was down 105653600.0% from 12211.61% recorded in Q2 2025.
- In the past 5 years, Silence Therapeutics' Net Margin registered a high of 48.61% during Q4 2024, and its lowest value of 313931.3% during Q1 2021.
- For the 5-year period, Silence Therapeutics' Net Margin averaged around 19369.82%, with its median value being 368.38% (2022).
- In the last 5 years, Silence Therapeutics' Net Margin surged by 2000000000bps in 2021 and then crashed by -200643600bps in 2025.
- Silence Therapeutics' Net Margin (Quarter) stood at 328.85% in 2021, then increased by 4bps to 315.84% in 2022, then tumbled by -126bps to 713.01% in 2023, then skyrocketed by 107bps to 48.61% in 2024, then crashed by -27213bps to 13181.13% in 2025.
- Its last three reported values are 13181.13% in Q3 2025, 12211.61% for Q2 2025, and 20091.55% during Q1 2025.